Commonwealth Equity Services’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.21M | Buy |
94,186
+375
| +0.4% | +$4.78K | ﹤0.01% | 2444 |
|
|
2025
Q4 | $843K | Buy |
93,811
+4,172
| +5% | +$57.4K | ﹤0.01% | 2724 |
|
|
2025
Q3 | $1.55M | Buy |
89,639
+22,445
| +33% | +$276K | ﹤0.01% | 2228 |
|
|
2025
Q2 | $630K | Buy |
67,194
+24,931
| +59% | +$205K | ﹤0.01% | 2971 |
|
|
2025
Q1 | $300K | Buy |
42,263
+11,499
| +37% | +$116K | ﹤0.01% | 3496 |
|
|
2024
Q4 | $359K | Buy |
30,764
+6,343
| +26% | +$99K | ﹤0.01% | 3255 |
|
|
2024
Q3 | $502K | Sell |
24,421
-3,116
| -11% | -$71.8K | ﹤0.01% | 2891 |
|
|
2024
Q2 | $616K | Sell |
27,537
-7,056
| -20% | -$168K | ﹤0.01% | 2658 |
|
|
2024
Q1 | $952K | Buy |
34,593
+2,034
| +6% | +$56.5K | ﹤0.01% | 2285 |
|
|
2023
Q4 | $993K | Buy |
32,559
+2,144
| +7% | +$61.6K | ﹤0.01% | 2186 |
|
|
2023
Q3 | $962K | Buy |
30,415
+1,910
| +7% | +$74.1K | ﹤0.01% | 2101 |
|
|
2023
Q2 | $1.16M | Buy |
28,505
+196
| +0.7% | +$7.95K | ﹤0.01% | 1989 |
|
|
2023
Q1 | $1.05K | Buy |
28,309
+1,123
| +4% | +$44K | ﹤0.01% | 2007 |
|
|
2022
Q4 | $948K | Buy |
27,186
+8,614
| +46% | +$410K | ﹤0.01% | 2001 |
|
|
2022
Q3 | $1.04M | Sell |
18,572
-2,433
| -12% | -$151K | ﹤0.01% | 1864 |
|
|
2022
Q2 | $1.09M | Sell |
21,005
-4,870
| -19% | -$247K | ﹤0.01% | 1822 |
|
|
2022
Q1 | $1.88M | Sell |
25,875
-704
| -3% | -$59.6K | ﹤0.01% | 1545 |
|
|
2021
Q4 | $3.14M | Buy |
26,579
+182
| +0.7% | +$22.8K | 0.01% | 1189 |
|
|
2021
Q3 | $3.54M | Sell |
26,397
-713
| -3% | -$108K | 0.01% | 1069 |
|
|
2021
Q2 | $4.39M | Buy |
27,110
+2,352
| +9% | +$183K | 0.01% | 928 |
|
|
2021
Q1 | $1.99M | Buy |
24,758
+199
| +0.8% | +$13.4K | 0.01% | 1331 |
|
|
2020
Q4 | $1.34M | Buy |
24,559
+390
| +2% | +$14.2K | ﹤0.01% | 1474 |
|
|
2020
Q3 | $480K | Buy |
24,169
+245
| +1% | +$5.11K | ﹤0.01% | 1992 |
|
|
2020
Q2 | $502K | Sell |
23,924
-5,414
| -18% | -$92K | ﹤0.01% | 1882 |
|
|
2020
Q1 | $358K | Buy |
29,338
+7,336
| +33% | +$98.8K | ﹤0.01% | 1943 |
|
|
2019
Q4 | $322K | Sell |
22,002
-1,323
| -6% | -$18.4K | ﹤0.01% | 2260 |
|
|
2019
Q3 | $311K | Buy |
23,325
+736
| +3% | +$11.7K | ﹤0.01% | 2209 |
|
|
2019
Q2 | $369K | Buy |
22,589
+8,440
| +60% | +$133K | ﹤0.01% | 2037 |
|
|
2019
Q1 | $241K | Buy |
14,149
+3,285
| +30% | +$49K | ﹤0.01% | 2327 |
|
|
2018
Q4 | $148K | Buy |
10,864
+1,863
| +21% | +$34.6K | ﹤0.01% | 2416 |
|
|
2018
Q3 | $257K | Sell |
9,001
-414
| -4% | -$12K | ﹤0.01% | 2300 |
|
|
2018
Q2 | $258K | Sell |
9,415
-268
| -3% | -$6.49K | ﹤0.01% | 2255 |
|
|
2018
Q1 | $204K | Buy |
+9,683
| New | +$238K | ﹤0.01% | 2390 |
|
|
2017
Q4 | – | Sell |
-11,296
| Closed | -$281K | – | 2707 |
|
|
2017
Q3 | $281K | Buy |
11,296
+536
| +5% | +$10.1K | ﹤0.01% | 2030 |
|
|
2017
Q2 | $172K | Buy |
10,760
+310
| +3% | +$4.33K | ﹤0.01% | 2281 |
|
|
2017
Q1 | $147K | Sell |
10,450
-350
| -3% | -$4.7K | ﹤0.01% | 2237 |
|
|
2016
Q4 | $142K | Buy |
+10,800
| New | +$162K | ﹤0.01% | 2146 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
